HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 200 filers reported holding HERON THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.17 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,334,338 | +104.8% | 6,149,842 | +130.7% | 0.54% | +203.9% |
| Q2 2023 | $3,092,542 | -2.0% | 2,665,984 | +27.6% | 0.18% | -62.4% |
| Q1 2023 | $3,154,831 | +23.1% | 2,089,292 | +103.9% | 0.48% | +3.9% |
| Q4 2022 | $2,561,956 | +357.5% | 1,024,782 | +2049.9% | 0.46% | +76.8% |
| Q1 2020 | $560,000 | +77.8% | 47,667 | +181.7% | 0.26% | +68.2% |
| Q2 2019 | $315,000 | -67.2% | 16,920 | -57.0% | 0.15% | -69.3% |
| Q1 2019 | $961,000 | -5.8% | 39,336 | 0.0% | 0.50% | -28.3% |
| Q4 2018 | $1,020,000 | +4.7% | 39,336 | +27.9% | 0.70% | +21.3% |
| Q3 2018 | $974,000 | – | 30,759 | – | 0.58% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG KEVIN C | 760 | $1,900 | 100.00% |
| Velan Capital Investment Management LP | 2,500,000 | $6,250,000 | 5.52% |
| GREAT POINT PARTNERS LLC | 6,360,161 | $15,900,403 | 3.12% |
| Cheyne Capital Management (UK) LLP | 318,008 | $795,020 | 1.39% |
| TANG CAPITAL MANAGEMENT LLC | 3,755,934 | $9,389,835 | 1.36% |
| Rubric Capital Management LP | 11,750,000 | $29,375,000 | 1.28% |
| Orchard Capital Management, LLC | 1,391,080 | $3,477,700 | 1.17% |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 267,028 | $667,570 | 0.81% |
| CM Management, LLC | 250,000 | $625 | 0.75% |
| Tejara Capital Ltd | 493,619 | $1,234,048 | 0.71% |